Related Experiment Video
Updated: May 1, 2026

08:27
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
13.7K
Ultra-sensitive graphene micro-ribbon integrated THz biosensor for breast cancer cell detection
Meraline Selvaraj1, B S Sreeja2
1Department of Electronics & Communication Engineering, College of Engineering Guindy, Anna University, Chennai 600025, India.
Methods (San Diego, Calif.)
|April 25, 2025
Summary
This study introduces a novel terahertz (THz) biosensor using graphene micro-ribbons for rapid, non-invasive breast cancer cell detection. The advanced sensor achieves ultra-high sensitivity, promising improved early cancer diagnostics.
Area of Science:
- Biomedical Engineering
- Terahertz (THz) Spectroscopy
- Biosensor Technology
Background:
- Rising cancer incidence necessitates advanced diagnostic tools.
- Early and rapid cancer cell detection is critical for effective treatment.
- Non-invasive diagnostic methods are highly desirable in clinical settings.
Purpose of the Study:
- To develop a novel metasurface-assisted biosensor for rapid, non-invasive detection of breast cancer cells.
- To enhance biosensor performance using graphene micro-ribbons for improved terahertz wave interaction.
- To evaluate the sensitivity, detection limit, and figure of merit for cancer cell sensing.
Main Methods:
- Design and fabrication of a metasurface-assisted biosensor operating in the THz regime.
- Incorporation of graphene micro-ribbons to enhance THz wave interaction.
- Characterization of biosensor performance using specific absorption peaks and frequency shifts.
Main Results:
- Demonstrated three distinct absorption peaks at 2.0012 THz, 2.8734 THz, and 3.2948 THz with high absorption rates.
- Achieved a maximum frequency shift of 49 GHz and a theoretical sensitivity of 3.5 THz/RIU.
- Reported a figure of merit of 6.81 RIU-1, a detection limit of 0.26 RIU, and a resolution of 0.91 THz.
Conclusions:
- The proposed THz biosensor offers ultra-high sensitivity and a low detection limit for breast cancer cells.
- The portable and miniaturized platform holds significant promise for non-invasive cancer diagnostics.
- The sensor's versatility allows for potential applications in diverse clinical and laboratory settings.

